Body

New therapy targets for amyloid disease

A major discovery is challenging accepted thinking about amyloids – the fibrous protein deposits associated with diseases such as Alzheimer's and Parkinson's – and may open up a potential new area for therapeutics.

It was believed that amyloid fibrils - rope-like structures made up of proteins sometimes known as fibres - are inert, but that there may be toxic phases during their formation which can damage cells and cause disease.

Chicken pox vaccine reduces shingles risk in kids -- study of 172,000 kids used EHRs

December 4 , 2009 (Oakland, Calif.) – Herpes zoster, also known as shingles, is very rare among children who have been vaccinated against chicken pox, according to a Kaiser Permanente study in the December issue of the Pediatric Infectious Diseases Journal.

Poisonous Poisson

In contrast to the exhaustive research into venom produced by snakes and spiders, venomous fish have been neglected and remain something of a mystery. Now, a study of 158 catfish species, published in the open access journal BMC Evolutionary Biology, has catalogued the presence of venom glands and investigated their biological effects.

Risk of blood clot after surgery higher and lasts longer than previously thought

The risk of having a potentially fatal blood clot after surgery is higher and lasts for longer than had previously been thought, concludes new research published on bmj.com today.

This has important implications as most patients receive preventive (anti-clotting) therapy only whilst in hospital, or for up to five weeks after certain high-risk operations. And those undergoing day surgery are unlikely to be considered for preventive therapy at all.

Popular diabetes drugs linked to increased risk of heart failure and death

Sulphonylureas, a type of drug widely used to treat type 2 diabetes, carries a greater risk of heart failure and death compared with metformin, another popular antidiabetes drug.

The findings, published on bmj.com today, suggest clinically important differences in the cardiovascular safety profiles of different antidiabetes drugs, and support recommendations that favour metformin as first-line therapy for type 2 diabetes.

Weight loss reduces sleep problems in obese men

Weight loss reduces obstructive sleep apnoea in obese men, with the greatest effect seen in patients with severe disease, according to new research published on bmj.com today.

Obstructive sleep apnoea is a common sleep disorder characterised by pauses in breathing during sleep. Each episode (apnoea) lasts for at least 10 seconds and is caused by the collapse of the upper airways during sleep.

Model predicts dialysis patients' likelihood of survival

A new model can help physicians determine if a kidney disease patient on dialysis is likely to die within the next few months, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). This clinical tool could help medical professionals initiate discussions with patients and their families about end-of-life care such as hospice.

Understanding DNA repair and cancer

A protein that plays a key role in copying DNA also plays a vital role in repairing breaks in it, UC Davis scientists have found. The work is helping researchers understand how cancer cells can resist radiation and chemotherapy, as well as how cells become cancerous in the first place.

The protein, known as proliferating cell nuclear antigen, forms a ring that fits around the DNA double helix. This cuff-like ring helps to keep in place DNA polymerase, the enzyme that makes a copy of the DNA strand when cells divide into two new cells.

Nevada professor devises new childhood obesity screening tools

RENO, Nev. – A University of Nevada, Reno professor who thinks the present weight management charts and screening tools for children are too difficult to understand and use has devised new, simpler charts that pediatricians and parents can use to help combat the increasing rates of obese and overweight children in the United States.

Study links real-time data to flu vaccine strategies

Adaptive vaccination strategies, based on age patterns of hospitalizations and deaths monitored in real-time during the early stages of a pandemic, outperform seasonal influenza vaccination allocation strategies, according to findings reported Dec. 3 by researchers, including two from Arizona State University, in the online journal PLoS ONE.

New drug technology produces marked improvement in hepatitis C therapy in animals

In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C

Hoersholm, Denmark/San Diego, California, December 3, 2009 — A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).

2 heads better than 1 when developing antibiotics

An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing new, more potent antibacterial drugs.

"A completely new way to beat bacteria is an exciting find at a time when resistance to existing antibiotics is growing," said Professor Tony Maxwell from the John Innes Centre, lead author on the research to be published in Science. JIC is an institute of the BBSRC.

Biodiversity-based carbon cap could stop large-scale extinctions

A new strategy for saving tropical forest species was published in the leading journal Science on the eve of the United Nations Framework Convention on Climate Change in Copenhagen, Denmark, by a team of researchers, including William Laurance, senior staff scientist at the Smithsonian Tropical Research Institute and distinguished professor at James Cook University. The authors state that wealthy countries should adopt a carbon-payment system that explicitly incorporates biodiversity values.

Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find

ALBUQUERQUE, N.M. — Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many bacteria must be present to start the process.

But the Jeff Brinker research group has determined that the very first stage of staph infection, when bacteria switch from a harmless to a virulent form, occurs in a single cell and that this individual process can be stopped by the application of a simple protein.